Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Copper-containing Intrauterine Device [EPC]
Juglans Regia Fruit Rind, Immature is a botanical extract categorized under several Pharmacologic Classes, including Non-Standardized Plant Allergenic Extracts, used primarily in diagnostic and therapeutic immunology.
Name
Juglans Regia Fruit Rind, Immature
Raw Name
JUGLANS REGIA FRUIT RIND, IMMATURE
Category
Copper-containing Intrauterine Device [EPC]
Drug Count
9
Variant Count
10
Last Verified
February 17, 2026
About Juglans Regia Fruit Rind, Immature
Juglans Regia Fruit Rind, Immature is a botanical extract categorized under several Pharmacologic Classes, including Non-Standardized Plant Allergenic Extracts, used primarily in diagnostic and therapeutic immunology.
Detailed information about Juglans Regia Fruit Rind, Immature
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Juglans Regia Fruit Rind, Immature.
Juglans Regia Fruit Rind, Immature, commonly known as the green husk of the English walnut, is a complex botanical substance utilized in modern clinical medicine primarily as a Non-Standardized Plant Allergenic Extract [EPC]. While its classification in some regulatory databases includes disparate categories such as Copper-containing Intrauterine Device [EPC] and l-Thyroxine [EPC], its primary clinical application involves the diagnosis and management of Type I hypersensitivities (immediate allergic reactions). The extract is derived from the outer pericarp (the fleshy green shell) of the walnut fruit before it reaches full maturity.
Historically, Juglans Regia has been utilized in traditional medicine for its astringent and antimicrobial properties, but its inclusion in the 2026 pharmacological landscape is strictly regulated by the FDA as an allergenic extract. It belongs to a class of drugs used to identify patients who are sensitized to walnut proteins, which is a critical step in preventing anaphylaxis (a severe, life-threatening allergic reaction). The FDA approval history of these extracts dates back several decades, with continuous refinement in the standardization of the manufacturing process to ensure consistent protein concentrations.
At the molecular level, Juglans Regia Fruit Rind, Immature works by introducing specific walnut-derived proteins—such as Jug r 1, Jug r 2, and Jug r 3—to the patient's immune system. In diagnostic settings, such as skin prick testing, these proteins interact with IgE (Immunoglobulin E) antibodies bound to the surface of mast cells (immune cells that release histamine). If the patient is sensitized, this interaction triggers mast cell degranulation, releasing histamine and other inflammatory mediators, which results in a visible 'wheal and flare' reaction (a raised, red bump on the skin).
Beyond its allergenic properties, the immature fruit rind contains a high concentration of juglone (5-hydroxy-1,4-naphthoquinone). Juglone is a bioactive compound that exhibits cytotoxic effects by inhibiting certain enzymes, such as RNA polymerase, and inducing oxidative stress within targeted cells. This mechanism is currently being researched for potential anti-neoplastic (cancer-fighting) and antimicrobial applications, although these remain largely experimental or off-label.
> Important: Only your healthcare provider can determine if Juglans Regia Fruit Rind, Immature is right for your specific condition. The use of allergenic extracts must be performed under the supervision of a qualified allergist or immunologist prepared to treat systemic reactions.
For diagnostic skin prick testing, the standard adult dosage involves the application of one drop (approximately 0.05 mL) of the 1:10 or 1:20 w/v extract to the forearm or back. If an intradermal test is required following a negative skin prick test, a much more dilute concentration (typically 1:1000 to 1:100 v/v) is used, with only 0.02 mL injected.
In the context of immunotherapy, the dosage is highly individualized. It typically begins with a 'build-up phase' where doses as low as 0.1 mL of a 1:100,000 dilution are administered once or twice weekly, gradually increasing over 3 to 6 months to a maintenance dose of 0.5 mL of a 1:100 or 1:10 dilution.
Juglans Regia Fruit Rind, Immature is approved for use in children; however, extreme caution is advised. For children under the age of 5, skin prick testing is preferred over intradermal testing due to the higher risk of systemic reactions. The dosage is generally the same as the adult skin prick dose (one drop), but the number of simultaneous tests performed may be limited to prevent excessive discomfort or systemic absorption.
No specific dosage adjustments are required for patients with renal impairment when the extract is used for diagnostic skin testing, as systemic absorption is minimal. However, in patients with end-stage renal disease, the skin's reactivity to histamine may be reduced, potentially leading to false-negative results.
No dosage adjustments are formally established for hepatic impairment. Because the extract is not intended for systemic maintenance, liver function does not typically impact the safety or efficacy of diagnostic procedures.
Elderly patients (over 65) may have reduced skin turgor and diminished mast cell responsiveness. While the dose remains the same, healthcare providers must interpret results carefully, as the wheal size may be smaller than in younger adults.
If a scheduled immunotherapy injection is missed, the next dose may need to be reduced depending on the length of the delay. If the delay is more than two weeks, the allergist will typically revert to a previous, lower dose to ensure safety. For diagnostic testing, a missed appointment simply requires rescheduling; there is no 'catch-up' protocol.
An overdose of Juglans Regia Fruit Rind, Immature extract usually manifests as an exaggerated local reaction (a wheal larger than 15mm) or a systemic allergic reaction. Emergency measures include the immediate administration of epinephrine (0.3 mg for adults), intravenous fluids, and antihistamines.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. If you experience difficulty breathing or swelling of the throat after a test, seek emergency medical help immediately.
The most frequent side effect associated with Juglans Regia Fruit Rind, Immature is a localized skin reaction at the site of administration. This is actually the intended effect in diagnostic testing. Patients typically experience:
Some patients may experience more persistent or spreading local reactions, including:
Rarely, the extract can trigger systemic symptoms that are not full-blown anaphylaxis but require monitoring:
> Warning: Stop taking Juglans Regia Fruit Rind, Immature and call your doctor immediately if you experience any of these.
When used for diagnostic purposes, there are no known long-term side effects. However, in the context of long-term immunotherapy, some patients may develop 'serum sickness-like' symptoms, including joint pain, fever, and rash, though this is exceptionally rare with plant-based extracts compared to animal-derived sera. Prolonged topical use of the rind extract can lead to skin hyperpigmentation (darkening) due to the presence of juglone, which acts as a natural dye.
While Juglans Regia Fruit Rind, Immature does not always carry a specific individual black box warning, all allergenic extracts are subject to the general FDA class warning for allergenic extracts:
Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. Patients should be observed for at least 30 minutes after administration. This product should only be administered by healthcare providers experienced in the diagnosis and treatment of severe allergic reactions and in a facility equipped with emergency supplies.
Report any unusual symptoms to your healthcare provider.
Juglans Regia Fruit Rind, Immature is a potent biological substance. It must be used with extreme caution in patients with a history of severe nut allergies, as the immature rind contains many of the same allergenic proteins found in the mature walnut. Patients must be screened for recent use of beta-blockers, as these medications can make anaphylaxis more difficult to treat and resistant to epinephrine.
No specific FDA black box warning exists specifically for the 'Juglans Regia Fruit Rind' as a standalone entity, but it falls under the mandatory class-wide warning for all allergenic extracts regarding the risk of anaphylaxis. Healthcare providers must ensure that an Epinephrine Auto-Injector or equivalent emergency kit is immediately available during use.
There is no evidence that Juglans Regia Fruit Rind, Immature affects the ability to drive or operate machinery, provided no systemic allergic reaction occurs. However, if antihistamines are administered to treat a local reaction, these may cause drowsiness.
Patients should avoid alcohol consumption for at least 24 hours after receiving the extract. Alcohol can increase peripheral vasodilation, which may potentially worsen a localized allergic reaction or accelerate the onset of systemic symptoms.
If a patient experiences a systemic reaction, the use of the extract must be discontinued immediately. Future testing or therapy should only be considered after a thorough risk-benefit analysis and potentially at a much higher dilution.
> Important: Discuss all your medical conditions with your healthcare provider before starting Juglans Regia Fruit Rind, Immature.
For each major interaction, the mechanism typically involves either a pharmacodynamic interference (blocking the receptors needed for the test to work) or a safety-related interference (blocking the medication needed to treat a side effect). The management strategy always involves a mandatory 'washout' period for interfering drugs before the extract is used.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Patients allergic to Juglans Regia Fruit Rind may also react to:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Juglans Regia Fruit Rind, Immature.
Juglans Regia Fruit Rind, Immature is classified as FDA Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. The primary concern is not the direct teratogenic effect of the extract but the potential for systemic anaphylaxis in the mother. Anaphylaxis causes a sudden drop in maternal blood pressure, which can lead to placental insufficiency and fetal distress. Therefore, diagnostic testing is generally avoided during pregnancy unless the information is critical for immediate management.
It is not known whether the components of the extract are excreted in human milk. Because the systemic absorption of the extract during skin testing is minimal, it is unlikely to affect a nursing infant. However, caution should be exercised, and the mother should be monitored for any systemic reactions that could indirectly affect breastfeeding.
Safety and effectiveness have been established in the pediatric population. However, the risk of a systemic reaction may be harder to monitor in very young children who cannot articulate early symptoms like throat tightness or nausea. Dose volumes are often kept at the lower end of the range, and the use of 'multi-test' devices may be preferred to minimize the number of punctures.
Clinical studies have not included sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. In general, elderly patients have a higher prevalence of cardiovascular disease and may be taking medications (like Beta-blockers or ACE inhibitors) that complicate the safety of allergenic extracts. Furthermore, skin reactivity decreases with age, which may increase the rate of false-negative results.
In patients with significant renal impairment, there are no specific dose adjustments required for the extract itself. However, clinicians should be aware that uremia (high levels of urea in the blood) can suppress the skin's response to histamine, which is the positive control used alongside Juglans Regia extract. If the histamine control is negative, the walnut test result cannot be considered valid.
There is no evidence that hepatic impairment alters the response to Juglans Regia Fruit Rind extract when used diagnostically. The proteins are primarily degraded locally by proteases or processed by the lymphatic system rather than requiring extensive hepatic clearance.
> Important: Special populations require individualized medical assessment and a cautious approach to diagnostic allergy testing.
Juglans Regia Fruit Rind, Immature acts through an immunological mechanism. The extract contains specific allergenic proteins (antigens) that, upon entering the dermis, cross-link IgE antibodies on the surface of local mast cells. This cross-linking triggers a signal transduction cascade involving tyrosine kinases, leading to the release of pre-formed mediators like histamine, proteoglycans, and serine proteases. These mediators act on H1 receptors in the surrounding vasculature to cause the 'wheal and flare' reaction.
Additionally, the rind contains juglone, which acts as a biological electrophile. It can undergo redox cycling to produce reactive oxygen species (ROS), which may contribute to the extract's historical use as an antimicrobial. In a diagnostic context, however, the protein-IgE interaction is the dominant pharmacological pathway.
The pharmacodynamic response is characterized by a rapid onset. The 'flare' (redness) typically appears within 5 to 10 minutes, followed by the 'wheal' (swelling) which reaches its maximum diameter at 15 to 20 minutes. The duration of the effect is relatively short, with the wheal usually resolving within 1 to 2 hours, although a late-phase reaction (characterized by cellular infiltration) can occur 4 to 8 hours later in some sensitive individuals.
| Parameter | Value |
|---|---|
| Bioavailability | <1% (Epicutaneous) |
| Protein Binding | N/A (Local action) |
| Half-life | 2-4 hours (Local tissue) |
| Tmax | 15-20 minutes (Pharmacodynamic) |
| Metabolism | Local Proteolysis |
| Excretion | Renal (Metabolites) |
The extract is a complex mixture. The primary bioactive naphthoquinone is Juglone (C10H6O3), with a molecular weight of 174.15 g/mol. It is poorly soluble in water but soluble in alcohol and oils. The allergenic proteins range in molecular weight from 10 kDa to 70 kDa. The extract also contains high concentrations of hydrolyzable tannins (e.g., ellagitannins).
Juglans Regia Fruit Rind, Immature is classified as a Non-Standardized Plant Allergenic Extract [EPC]. It is related to other tree nut extracts like Carya illinoinensis (Pecan) and Corylus avellana (Hazelnut). Within the broader therapeutic area, it is considered a diagnostic biological agent used in allergy and immunology.
Medications containing this ingredient
Common questions about Juglans Regia Fruit Rind, Immature
Juglans Regia Fruit Rind, Immature is primarily used as a diagnostic tool to identify individuals with an allergy to English walnuts. In a clinical setting, an allergist applies a small amount of the extract to the skin to see if a localized reaction occurs. This helps in diagnosing food allergies or respiratory sensitivities. It is also used in some cases for allergen immunotherapy, which involves desensitizing the patient to the allergen over time. Additionally, it has historical and off-label uses as a topical astringent due to its high tannin content.
The most common side effects are localized to the site of the skin test and include itching, redness, and a raised bump known as a wheal. These symptoms are expected and indicate the body's immune response to the walnut proteins. Most local reactions resolve on their own within a few hours. Some patients may experience a 'late-phase' reaction where the area becomes swollen again several hours later. If the itching is bothersome, a doctor may suggest a topical cream or an oral antihistamine after the test is completed.
It is generally advised to avoid alcohol for at least 24 hours after receiving a Juglans Regia extract test or injection. Alcohol can cause blood vessels to dilate, which might increase the severity of a local reaction or potentially speed up the onset of a systemic allergic reaction. Furthermore, alcohol can mask some of the early warning signs of an allergic response, such as flushing or a rapid heartbeat. Always follow the specific post-test instructions provided by your allergist. If you have consumed alcohol recently, inform your doctor before the test begins.
The use of Juglans Regia Fruit Rind, Immature is generally deferred during pregnancy. While the extract itself is not known to harm the fetus directly, the risk of a severe allergic reaction (anaphylaxis) in the mother poses a significant danger. Anaphylaxis can lead to a dangerous drop in blood pressure, which may reduce the oxygen supply to the baby. Doctors typically wait until after the baby is born to perform allergy skin testing. If testing is absolutely necessary, it must be done with extreme caution in a specialized facility.
When used for diagnostic skin testing, the extract works very quickly. You will typically see a reaction on the skin within 5 to 10 minutes of application. The test is usually 'read' or measured by a healthcare professional at the 15 to 20-minute mark, which is when the reaction is at its peak. If you are undergoing immunotherapy (allergy shots), it takes much longer to see results. It can take several months of regular injections to reach a maintenance dose and up to a year to notice a significant reduction in allergy symptoms.
For diagnostic skin testing, there is no 'stopping' the medication as it is a one-time application. However, if you are receiving immunotherapy injections, you should not stop the schedule without consulting your allergist. Stopping suddenly will cause you to lose the immunological tolerance you have built up, and you may have to start the process over from the beginning. If you need to stop due to a side effect, your doctor will provide a safe plan for discontinuation. Always discuss any changes to your treatment plan with your medical provider.
If you miss an appointment for a diagnostic skin test, you should simply reschedule it as soon as possible. There are no health risks associated with missing a diagnostic test other than a delay in your diagnosis. If you miss an immunotherapy injection, contact your allergist immediately. Depending on how many days have passed since your last shot, your doctor may need to reduce the dose of your next injection to prevent an allergic reaction. Do not attempt to 'double up' on doses to make up for a missed one.
There is no clinical evidence to suggest that Juglans Regia Fruit Rind, Immature causes weight gain. The extract is used in very small amounts for diagnostic testing or immunotherapy, and it does not contain calories or hormones that affect metabolism or appetite. If you notice weight changes while undergoing allergy treatment, it is likely due to other factors, such as lifestyle changes or other medications you may be taking. Always discuss unexpected weight changes with your healthcare provider to determine the underlying cause.
Juglans Regia extract can interact with several types of medications, some of which can be dangerous. Most importantly, beta-blockers used for heart conditions or high blood pressure can make allergic reactions harder to treat. Antihistamines and certain antidepressants can interfere with the test results by preventing the skin from reacting. It is crucial to provide your doctor with a full list of all medications, including over-the-counter drugs and herbal supplements, before you have an allergy test. Your doctor will tell you which ones to stop taking and for how long.
Juglans Regia Fruit Rind, Immature is a biological product rather than a simple chemical drug, so the term 'generic' does not apply in the traditional sense. However, various manufacturers produce 'non-standardized' versions of the extract that are essentially equivalent. These are typically marketed under the common name of the plant. Because these are biological extracts, they are regulated differently than generic pills. Your allergist will select a high-quality, FDA-cleared extract from a reputable manufacturer to ensure the accuracy and safety of your allergy testing.